Finance
Immunotherapies company reports Q2 revenue of $1 million
Published in Vaccine Weekly, August 31st, 2005
Total revenues for the quarter ended June 30, 2005, were $1 million compared to $5.5 million for the same period in 2004. Revenues in the second quarter of 2005 reflect a decrease in collaboration revenue following the March 2005 ending of the allergy collaboration between Dynavax and UCB Farchim (UCB) and the return to Dynavax of full rights to its allergy program.
Revenues in the second-quarter 2005 were driven by grants awarded by the U.S. National Institute of Allergy and Infectious Diseases and by the Alliance for Lupus Research. For the 6 months ended June...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-31)
More Articles from Vaccine Weekly
- Cancer Vaccine
Electrofusion process can increase immunogenicity of human cells - Ebola Vaccine
Live vaccine protects primates against Ebola and Marburg viruses - Herpes Vaccine
Plasmid-encoded IL-15 protects against herpes virus - Neurocysticercosis Vaccine
Vaccination of pigs controls human neurocysticercosis - Tuberculosis Vaccine
Multicomponent antituberculous vaccine developed - Adenovirus Vector
Capsid modifications enable flexible targeting of adenovirus vectors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
